Evidence map›Paper›PMID 33228562›Full record

Trial reportBMC infectious diseases2020

Pharmacist-led counselling intervention to improve antiretroviral drug adherence in Pakistan: a randomized controlled trial.

Zeenat Fatima Chatha, Usman Rashid, Sharon Olsen, Fakhar Ud Din, Amjad Khan, Komal Nawaz, Siew Hua Gan, Gul Majid Khan

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Zeenat Fatima ChathaDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Usman RashidHealth and Rehabilitation Research Institute, Auckland University of Technology (AUT), Auckland, New Zealand.
Sharon OlsenHealth and Rehabilitation Research Institute, Auckland University of Technology (AUT), Auckland, New Zealand.
Fakhar Ud DinDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan. fudin@qau.edu.pk.ORCID http://orcid.org/0000-0001-9537-4897
Amjad KhanDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan. amjadkhan@qau.edu.pk.
Komal NawazDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Siew Hua GanSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Gul Majid KhanDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan. gmkhan@qau.edu.pk.
Quaid-i-Azam University · PKAuckland University of Technology · NZMonash University Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPakistan is facing a growing population of people living with human immunodeficiency (HIV). In this randomized controlled trial, we investigate if a pharmacist-led intervention can increase adherence to antiretroviral therapy (ART) for people living with HIV (PLWH).

methodsAdults with HIV, who have been taking ART for more than 3 months were randomly assigned to receive either a pharmacist-led intervention or their usual care. Measures of adherence were collected at 1) baseline 2) just prior to delivery of intervention and 3) 8 weeks later. The primary outcomes were CD4 cell count and self-reported adherence measured with the AIDS Clinical Trial Group (ACTG) questionnaire.

resultsPost-intervention, the intervention group showed a statistically significant increase in CD4 cell counts as compared to the usual care group (p = 0.0054). In addition, adherence improved in the intervention group, with participants being 5.96 times more likely to report having not missed their medication for longer periods of time (p = 0.0086) while participants in the intervention group were 7.74 times more likely to report missing their ART less frequently (p < 0.0001).

conclusionsThe findings support the improvement in ART adherence and HIV management.

trial registrationThe trial is registered with Australian New Zealand Clinical Trials Registry ( ACTRN12618001882213 ). Registered 20 November 2018.

Indexed as

AdultAnti-Retroviral AgentsCD4 Lymphocyte CountCounselingFemaleHIVHIV InfectionsHumansMaleMedication AdherenceMiddle AgedPakistanPharmacistsRisk FactorsSelf ReportSingle-Blind MethodAnti-Retroviral AgentsART adherenceCounsellingHIVPharmacist interventionPrevention

Identifiers

PMID33228562
PMCPMC7684945
OpenAlexW3106989608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.